Quanta Therapeutics Stock

www.quantatx.comHealthcareFounded: 2018

Quanta Therapeutics, founded in 2018, is a biopharmaceutical company that creates drugs designed for oncology treatments. The company also develops allosteric modulation aiming to directly restore conformational control of active RAS signaling at the cell membrane, with the goal of inhibiting the full scope of RAS-driven cancer types, thereby enabling researchers to break the resistance paradigms of targeted therapy in oncology. Quanta Therapeutics is headquartered in San Francisco, California.

Register for Details

For more details on financing and valuation for Quanta Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Quanta Therapeutics.

Register Today

Quanta Therapeutics investors also invested in these private companies

Longitude Capital
Avidity Partners
Vida Ventures (Boston)
AbbVie Ventures
BVF Partners

Team

Management Team

Cameron Pitt Ph.D
Co-Founder, Chief Business Officer & Chief Financial Officer
Frank McCormick Ph.D
Co-Founder
Leonardo Faoro
Chief Medical Officer
Perry Nisen MD
Chief Executive Officer
Derek Metzger
Vice President of Strategy and Finance

Board Members

Arjun Goyal MD
Vida Ventures
Maha Katabi Ph.D
Sofinnova Investments

Other companies like Quanta Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B